Although the mechanism of inhibitor development in patients with hemophilia is still not completely understood, several factors might be involved such as family history, ethnicity, FVIII gene mutation type, treatment intensity and other unknown environmental factors (30, 31). The gene discussed is F8; the disease is hemophilia.